Pro-inflammatory cytokine secretion pathways

Pro-inflammatory cytokine secretion pathways represent the coordinated biological processes responsible for the synthesis, processing, and extracellular release of signaling proteins that drive inflammatory responses (Nature Reviews Immunology, 2018). These pathways are typically initiated by the recognition of pathogens or cellular stress by pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs) (Frontiers in Immunology, 2021). Key intracellular events include the activation of the NF-kappaB transcription factor and the assembly of the inflammasome complex, which processes pro-cytokines like IL-1 beta into their active forms (StatPearls, 2023). Dysregulation of these pathways leads to excessive cytokine production, contributing to the pathogenesis of chronic inflammatory conditions, autoimmune diseases, and acute systemic responses like cytokine storms (NIH, 2024). Therapeutic strategies often focus on specific nodes within these pathways, such as neutralizing monoclonal antibodies or small-molecule inhibitors of signaling kinases like JAK (PubMed, 2022). While highly effective in controlling inflammation, modulating these pathways requires careful management due to the potential for significant immunosuppression and increased infection risk (Journal of Clinical Investigation, 2020).

Other names

Cytokine release pathwaysInflammatory signaling cascadesPro-inflammatory cytokine productionCytokine secretion signaling

Inhibition of cytokine synthesis, neutralization of secreted cytokines, blockade of cytokine receptors, or inhibition of downstream intracellular signaling molecules such as JAK/STAT or NF-kappaB.